Schrader R., J. Klein, J. Medal, J. Marín, N. Salazar, M. Barrera, C. Albornoz, M. Chandía, X. Errazu, R. Becerra, G. Sylvester, J. C. Jiménez, E. Vargas. 2007. Progress in Chile in the development of the fission 99Mo production using modified CINTICHEM. Presentation at the 2007 International RERTR Meeting, Prague, Czech Republic, September 23-27. Available at http://www.rertr.anl.gov/RERTR29/PDF/9-4_Schrader.pdf.

Shah D. J., R. M. Judd, and R. J. Kim. 2005. Technology insight: MRI of the myocardium. Nat Clin Pract Cardiovasc Med 2(11):597-605.

SNM (Society for Nuclear Medicine). 2008. Preliminary Draft Report of the SNM Isotope Availability Task Group. June. Available at http://interactive.snm.org/docs/DRAFT_report_7.15.08.pdf.

Solbrekken, G. L., A. S. El-Gizawy, and C. Allen. 2008. Engineering design of LEU foil based target for high volume production of Mo-99. 2008 International RERTR Meeting, Washington, DC, October 5-9.

Takács S., F. Tárkányi, M. Sonck, and A. Hermanne. 2002. Investigation of the natMo(p,x)96mgTc nuclear reaction to monitor proton beams: New measurements and consequences on the earlier reported data. Nucl Inst Method in Phy Res B 198:183-196.

Takács S., Z. Szűcs, F. Tárkányi, A. Hermanne, and M. Sonck. 2003. Evaluation of proton induced reactions on 100Mo: New cross sections for production of 99mTc and 99Mo. Radioanal Nucl Chem 257(1):195-210.

TRIUMF. 2008. Making Medical Isotopes: Report of the Task Force on Alternatives for Medical-Isotope Production. Available at http://admin.triumf.ca/facility/5yp/comm/Report-vPREPUB.pdf.

USNRC (U.S. Nuclear Regulatory Commission). 1988. Safety Evaluation Report Related to the Evaluation of Low-Enriched Uranium Silicide-Aluminum Dispersion Fuel for Use in Non-Power Reactors. NUREG-1313, July. Rockville, MD: USNRC.

Vandegrift, G. 2005. Facts and Myths Concerning 99Mo Production with HEU and LEU Targets. Presentation at the 2005 International RERTR Meeting, Boston, MA, November 6-10. Available at http://www.rertr.anl.gov/RERTR27/PDF/S8-1_VandeGrift.pdf.

Vandegrift G. F., A. J. Bakel, and J. W. Thomas. 2007. Overview of 2007 ANL progress for conversion of HEU-based Mo-99 production as part of the U.S. global threat reduction–conversion program. Presentation at the 2007 International RERTR Meeting, Prague, Czech Republic, September 23-27. Available at http://www.rertr.anl.gov/RERTR29/PDF/6-2_Vandegrift.pdf.

Vandegrift, G., J. Fortner, A. Bakel, S. Chemerisov, A. Gelis, J. Jerden, D. Stepinski, and A. Zeigler. 2008. Overview of Argonne progress related to implementation of Mo-99 production by use of a homogeneous reactor. Presentation at the 2008 International RERTR Meeting, Washington, DC, October 5-9.

van der Schaaf, B., F. J. Blom, K. O. Broekhaus, and R. Jansma. 2008. Pallas, the New Petten Research and Isotope Reactor. Proceedings of the Research Reactor Fuel Management Conference, Hamburg, Germany, March 2-5.

von Hippel, F. N., and L. H. Kahn. 2006. Feasibility of eliminating the use of highly enriched uranium in the production of medical radioisotopes. Science and Global Security 14:151-162.

Wiencek, T. C., G. F. Vandegrift, A. Bakel, A. A. Leyva, and A. S. Hebden. 2008. Status and progress of foil and target fabrication activities for the production of 99Mo from LEU. Presentation at the 2008 International RERTR Meeting, Washington, DC, October 5-9.

Ziegler, A. J., D. C. Stepinski, J. F. Krebs, S. D. Chemerisov, A. J. Bakel, and G. F. Vandegrift. 2008. Mo-99 recovery from aqueous-homogenous-reactor fuel-behavior of termoxid sorbents. Presentation at the 2008 International RERTR Meeting, Washington, DC, October 5-9.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement